$1.61
-0.035-2.13%
Last update: Nov 10, 5:35 PM
Elicio Therapeutics Inc
ELTXNASDAQ
The average analyst price target for Elicio Therapeutics is $14.50, 784.1% above the current price. Of 5 analysts, 4 rate it Buy and 1 Hold. Targets range from $8 to $21. The latest change came on Nov 10, 2026, when HC Wainwright & Co. lowered its price target on Elicio Therapeutics from $23 to $21 and kept a Buy rating.
Price Target Range — 10 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months
